17 min listen
The Philips consent decree and the path forward
FromTalking Sleep
ratings:
Length:
54 minutes
Released:
May 17, 2024
Format:
Podcast episode
Description
After nearly three years, the Department of Justice and the Food and Drug Administration have finally agreed to the terms of a consent decree with Philips. It states that Philips Respironics cannot manufacture or distribute new sleep and respiratory care devices in the U.S. market until certain criteria are met, unless the devices are classified by the FDA as “medically necessary.” The scope of the recall is far larger than just consumer PAP devices. This impacts sleep diagnostics – including Alice polysomnography systems, home sleep apnea test platforms, and in-lab titration devices. Here to help us understand the specifics of the consent decree are Drs. Peter Gay, Aneesa Das, and Robert Owens.
Released:
May 17, 2024
Format:
Podcast episode
Titles in the series (90)
Medical Marijuana and OSA: The POTcast: Is there evidence that medical marijuana is an effective treatment for obstructive sleep apnea? Find out when we talk to Dr. Bhanu Kolla, an addiction psychiatrist and sleep physician who studies the interaction between sleep disturbances and addicti... by Talking Sleep